Related Experiment Videos
[Gene therapy]
1Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|March 26, 2003
Summary
Gene therapy offers novel treatments for hereditary diseases at the genetic level, targeting conditions like cancer and hemophilia. Ensuring safety and addressing ethical concerns are crucial for advancing this innovative medical field.
Area of Science:
- Biotechnology
- Molecular Biology
- Medical Genetics
Context:
- Gene therapy represents a paradigm shift in treating genetic disorders by targeting diseases at their molecular origin.
- Hereditary diseases such as cancer, hemophilia, and arteriosclerosis obliterans are increasingly being explored for gene therapy interventions.
- The development of gene medical supplies, including antisense oligonucleotides and decoy molecules, expands therapeutic options.
Purpose:
- To review recent advancements in gene therapy approaches for major diseases.
- To introduce novel gene medical supplies like antisense and decoys.
- To highlight critical safety and ethical considerations in gene therapy research and application.
Summary:
- This paper explores cutting-edge gene therapy strategies for cancer, hemophilia, and arteriosclerosis obliterans.
- It details the application of gene medical supplies, such as antisense and decoys.
- The study acknowledges a reported fatality linked to adenovirus vector-mediated gene therapy due to disseminated intravascular coagulation (DIC).
Impact:
- Gene therapy holds significant promise for treating previously intractable hereditary diseases.
- Addressing safety concerns, including rare but severe adverse events like DIC, is paramount for clinical translation.
- Resolving ethical dilemmas is essential for the responsible development and widespread adoption of gene therapy.